ARGX
argenx SENASDAQHealthcare$746.42+0.44%ClosedMarket Cap: $46.19B
As of 2026-04-06
Valuation
P/E (TTM)
21.43
PEG
0.01
P/B
6.25
P/S
13.66
EV/EBITDA
44.23
DCF Value
$-11,100.66
FCF Yield
1.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
89.0%
Operating Margin
25.6%
Net Margin
33.4%
ROE
16.8%
ROA
13.4%
ROIC
11.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $2.41B | 89.3% | $658.6M | $874.9M | $13.22 | — |
| FY 2025 | $4.16B | 89.1% | $972.5M | $1.30B | $19.63 | — |
| Q2 2025 | $948.0M | 88.3% | $201.1M | $245.4M | $6.37 | — |
| Q1 2025 | $790.7M | 89.8% | $138.9M | $169.5M | $2.58 | — |
| Q4 2024 | $1.35B | 50.6% | $117.2M | $865.6M | $12.20 | — |
| FY 2024 | $2.19B | 89.6% | $-21.7M | $833.0M | $12.78 | — |
| Q3 2024 | $573.2M | 89.7% | $14.2M | $91.4M | $1.39 | — |
| Q2 2024 | $901.9M | 142.1% | $-138.9M | $-32.5M | $-0.55 | — |
| Q1 2024 | $401.0M | 89.2% | $-93.4M | $-61.6M | $-1.04 | — |
| Q4 2023 | $757.7M | 24.3% | $-219.2M | $-155.6M | $-2.95 | — |
| FY 2023 | $1.23B | 90.4% | $-425.0M | $-295.1M | $-5.16 | — |
| Q3 2023 | $329.8M | 89.1% | $-80.6M | $-72.6M | $-1.25 | — |